Colette J Shen
Overview
Explore the profile of Colette J Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang B, Bukowski A, Kaidar-Person O, Choi J, Sasaki-Adams D, Jaikumar S, et al.
J Neurooncol
. 2024 Nov;
171(2):473-483.
PMID: 39543051
Purpose: Toxicities associated with stereotactic radiosurgery (SRS) are important when considering treatment and supportive management for patients with brain metastases. We herein assessed the association between brain metastasis location and...
2.
Casey D, Murphy E, Shen C, Milgrom S, Larrier N, Bradley J, et al.
Pract Radiat Oncol
. 2024 Oct;
PMID: 39447866
Purpose: Despite the urgent need for improved outcomes in patients with metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS), it is unknown how to best approach metastatic-site radiation therapy for these...
3.
Oh J, Skinner L, Gutkin P, Jiang A, Donaldson S, Loo Jr B, et al.
Adv Radiat Oncol
. 2024 Sep;
9(10):101589.
PMID: 39309703
Purpose: The Audiovisual-Assisted Therapeutic Ambience in Radiotherapy (AVATAR) trial was a prospective multicenter study (NCT03991156) examining the combination of video immersion with radiation therapy and was successfully conducted through the...
4.
Morse R, Nelson T, Liu H, Sangchan P, Chitti B, Thompson C, et al.
Int J Radiat Oncol Biol Phys
. 2024 Sep;
121(3):684-692.
PMID: 39307324
Purpose: Randomized trials have found that patients with locoregionally advanced p16+ oropharyngeal squamous cell carcinoma (OPSCC) do not benefit from treatment deintensification, even among favorable risk groups. Although various methods...
5.
Chen X, Sher D, Sullivan C, Repka M, Shen C, Chera B
Pract Radiat Oncol
. 2024 Apr;
14(4):328-333.
PMID: 38636587
Delineation of the clinical target volume (CTV) after resection of head and neck cancer can be challenging, especially after flap reconstruction. The main area of contention is whether the entire...
6.
Shen C, Kry S, Buchsbaum J, Milano M, Inskip P, Ulin K, et al.
Int J Radiat Oncol Biol Phys
. 2023 Aug;
119(2):431-445.
PMID: 37565958
Purpose: Few reports describe the risks of late ocular toxicities after radiation therapy (RT) for childhood cancers despite their effect on quality of life. The Pediatric Normal Tissue Effects in...
7.
Gutkin P, Skinner L, Jiang A, Donaldson S, Loo Jr B, Oh J, et al.
Int J Radiat Oncol Biol Phys
. 2023 Mar;
117(1):96-104.
PMID: 37001762
Purpose: The Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) system was the first published radiation therapy (RT)-compatible system to reduce the need for pediatric anesthesia through video-based distraction. We evaluated...
8.
Shen C, Terezakis S
Front Oncol
. 2021 Oct;
11:679701.
PMID: 34604027
Ongoing rapid advances in molecular diagnostics, precision imaging, and development of targeted therapies have resulted in a constantly evolving landscape for treatment of pediatric cancers. Radiotherapy remains a critical element...
9.
Sud S, Weiner A, Wang A, Gupta G, Shen C
Semin Radiat Oncol
. 2021 Aug;
31(4):309-323.
PMID: 34455986
Human papillomavirus (HPV) causes the majority of oropharyngeal, cervical, and anal cancers, among others. These HPV-associated cancers cause substantial morbidity and mortality despite ongoing vaccination efforts. Aside from the earliest...
10.
Chera B, Sheth S, Patel S, Goldin D, Douglas K, Green R, et al.
Cancer
. 2021 Aug;
127(23):4447-4454.
PMID: 34379792
Background: Adavosertib (AZD1775) is an inhibitor of the Wee1 kinase. The authors conducted a phase 1b trial to evaluate the safety of adavosertib in combination with definitive chemoradiotherapy for patients...